Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (63 ops.)
Latest filing published 07 Oct 2026 for Recursion Pharmaceuticals, INC., €216k. Read the official filing
Filing timeline
BuySaleBlake Borgeson
Insider track record
Disclosed buys
0
Disclosed sells
63
Signal history
Blake Borgeson: trading record in brief
Blake Borgeson is a declared insider of Recursion Pharmaceuticals, Inc. (board member), with filings sourced from SEC (Form 4). The record holds 79 filings, for trades running from 1 July 2021 to 6 October 2026.
The open-market record consists of 63 sales worth €8.4M, with no purchase. The rest of the record consists of 15 share grants. So far in 2026, the count stands at no purchases and 8 sales.
On 7 October 2026 came the latest disclosure, an open-market sale for €216k in Recursion Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Blake Borgeson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations79 total
50,000 shares@ US$4.84Class A Common StockSEC:0001601830-26-000120:0
30,000 shares@ US$3.25Class A Common StockSEC:0001856094-26-000014:0
40,000 shares@ US$3.96250.0090% mcap1.7% of flowClass A Common StockSEC:0001856094-26-000011:0
88,424 sharesClass A Common StockSEC:0001601830-26-000088:0
30,000 shares@ US$3.680.0051% mcap1.1% of flowClass A Common StockSEC:0001856094-26-000008:0
30,000 shares@ US$3.101.0% of flowClass A Common StockSEC:0001856094-26-000003:0
170,000 shares@ US$3.466.0% of flowClass A Common StockSEC:0001601830-26-000045:0
220,000 shares@ US$4.209.4% of flowClass A Common StockSEC:0001601830-26-000007:0
220,000 shares@ US$4.369.8% of flowClass A Common StockSEC:0001856094-26-000002:0
220,000 shares@ US$4.379.9% of flowClass A Common StockSEC:0001856094-25-000006:0
22,016 shares0Class A Common StockSEC:0001601830-25-000112:0
1,734 shares0Class A Common StockSEC:0001601830-25-000004:0
11,447 shares@ US$7.64021.0% of flowClass A Common StockSEC:0001601830-24-000205:0
11,447 shares@ US$6.72020.9% of flowClass A Common StockSEC:0001601830-24-000186:0
11,447 shares@ US$6.66780.8% of flowClass A Common StockSEC:0001601830-24-000179:0
2,026 shares0Class A Common StockSEC:0001601830-24-000174:0
11,447 shares@ US$6.21560.8% of flowClass A Common StockSEC:0001601830-24-000166:0
11,447 shares@ US$6.84310.8% of flowClass A Common StockSEC:0001601830-24-000160:0
11,447 shares@ US$6.26520.8% of flowClass A Common StockSEC:0001601830-24-000154:0
11,447 shares@ US$7.12260.9% of flowClass A Common StockSEC:0001601830-24-000129:0
11,447 shares@ US$6.82130.9% of flowClass A Common StockSEC:0001601830-24-000119:0
11,447 shares@ US$8.47741.1% of flowClass A Common StockSEC:0001601830-24-000104:0
11,447 shares@ US$7.3150.9% of flowClass A Common StockSEC:0001601830-24-000100:0
1,441 shares0Class A Common StockSEC:0001601830-24-000096:0
11,447 shares@ US$9.50521.2% of flowClass A Common StockSEC:0001601830-24-000094:0
25 of 79 declarations
